跳转至内容
Merck
CN

13433

碳酸氢钠

puriss., meets analytical specification of Ph. Eur., BP, USP, FCC, E500, 99.0-100.5%, powder

别名:

碳酸氢钠, 小苏打

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

线性分子式:
NaHCO3
化学文摘社编号:
分子量:
84.01
NACRES:
NA.21
PubChem Substance ID:
eCl@ss:
38020213
UNSPSC Code:
12352302
EC Number:
205-633-8
MDL number:
Beilstein/REAXYS Number:
4153970
Assay:
99.0-100.5%
Form:
powder
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


grade

puriss.

Quality Level

assay

99.0-100.5%

form

powder

quality

meets analytical specification of Ph. Eur., BP, USP, FCC, E500

impurities

ammonia (NH3), in accordance, organic volatile impurities, complies, residual solvents, complies, water-insoluble matter, complies, ≤0.002% ammonium (NH4), complies

loss

≤0.2% loss on drying (silica gel)

pH

≤8.6 (20 °C, 5%)

pKa (25 °C)

(1) 6.37, (2) 10.25 (carbonic acid)

density

2.16 g/mL at 25 °C (lit.)

anion traces

carbonate (CO32-): in accordance, chloride (Cl-): ≤100 mg/kg, sulfate (SO42-): ≤100 mg/kg

cation traces

Al: ≤0.5 mg/kg, As: ≤2 mg/kg, Ca: ≤100 mg/kg, Fe: ≤10 mg/kg, Hg: ≤1 mg/kg, K: ≤100 mg/kg, Pb: ≤2 mg/kg

suitability

complies for appearance of solution

SMILES string

[Na+].OC([O-])=O

InChI

1S/CH2O3.Na/c2-1(3)4;/h(H2,2,3,4);/q;+1/p-1

InChI key

UIIMBOGNXHQVGW-UHFFFAOYSA-M

Application

碳酸氢钠可能参与基于二氧化硅的整体柱的制造,可用于毛细管电色谱。也可用于通过离子交换置换色谱法维持色谱柱的 pH 值,用于蛋白质的分离。


Still not finding the right product?

Explore all of our products under 碳酸氢钠


flash_point_f

Not applicable

flash_point_c

Not applicable

存储类别

11 - Combustible Solids



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库



Use of the sodium salt of poly (vinylsulfonic acid) as a low-molecular-weight displacer for protein separations by ion-exchange displacement chromatography
Jen D.C.S and Pinto.GN
Journal of Chromatography A, 519(1), 87-98 (1990)
Silica-based monoliths for capillary electrochromatography: Methods of fabrication and their applications in analytical separations
Allen D and Rassi EZ
Electrophoresis, 24, 3962-3976 (2003)
Sophia Zoungas et al.
Annals of internal medicine, 151(9), 631-638 (2009-11-04)
Intravenous sodium bicarbonate has been proposed to reduce the risk for contrast-induced nephropathy (CIN). To determine the effect of sodium bicarbonate on the risk for CIN. MEDLINE, PubMed, EMBASE, and the Cochrane Central Register of Controlled Trials from 1950 to



全球贸易项目编号

货号GTIN
307505-5G04061826673607
307505-1G04061826673591
13433-1KG-R04061838729965
13433-5KG-R04061833458679
13433-4X5KG-R04061838729972